These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21129883)

  • 21. Preparation and evaluation of novel metronidazole sustained release and floating matrix tablets.
    Asnaashari S; Khoei NS; Zarrintan MH; Adibkia K; Javadzadeh Y
    Pharm Dev Technol; 2011 Aug; 16(4):400-7. PubMed ID: 20429828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained release dosage forms dissolution behavior prediction: a study of matrix tablets using NIR spectroscopy.
    Tabasi SH; Moolchandani V; Fahmy R; Hoag SW
    Int J Pharm; 2009 Dec; 382(1-2):1-6. PubMed ID: 19660535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of formulation and process variables on the release of a weakly basic drug from single unit extended release formulations.
    Kranz H; Wagner T
    Eur J Pharm Biopharm; 2006 Jan; 62(1):70-6. PubMed ID: 16154330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of hydrophilic, hydrophobic and waxy matrix excipients for sustained release tablets of venlafaxine hydrochloride.
    Yadav K; Yadav D; Srivastava AK
    Drug Dev Ind Pharm; 2013 Aug; 39(8):1197-206. PubMed ID: 22803761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and characterization of mucoadhesive nanosuspension of ciprofloxacin.
    Jain V; Kare P; Jain D; Singh R
    Acta Pol Pharm; 2011; 68(2):273-8. PubMed ID: 21485301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of drying methods on the physicochemical and compressional characteristics of Okra powder and the release properties of its metronidazole tablet formulation.
    Bakre LG; Jaiyeoba KT
    Arch Pharm Res; 2009 Feb; 32(2):259-67. PubMed ID: 19280157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of ethylcellulose and propylene glycol on the controlled-release performance of glyceryl monooleate-mertronidazole periodontal gel.
    Sallam AS; Hamudi FF; Khalil EA
    Pharm Dev Technol; 2015 Mar; 20(2):159-68. PubMed ID: 24262092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential Use of Polyvinyl Acetate-Polyvinylpyrrolidone Mixture for the Development of Atenolol Sustained Release Matrix Tablets: Optimization of Formulation through in Vitro-in Vivo Assessment Study.
    Owayez AS; Abd El-Ghany GM; Abu Hashim II
    Chem Pharm Bull (Tokyo); 2017; 65(6):545-557. PubMed ID: 28566647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Compatibility studies of nateglinide with excipients in immediate release tablets.
    Pani NR; Nath LK; Acharya S
    Acta Pharm; 2011 Jun; 61(2):237-47. PubMed ID: 21684850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of dissolution media composition on drug release and in-vitro/in-vivo correlation for paracetamol matrix tablets prepared with novel carbomer polymers.
    Parojcić J; Ethurić Z; Jovanović M; Ibrić S; Jovanović D
    J Pharm Pharmacol; 2004 Jun; 56(6):735-41. PubMed ID: 15231038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: drug release and fronts movement kinetics.
    Marinich JA; Ferrero C; Jiménez-Castellanos MR
    Eur J Pharm Biopharm; 2012 Apr; 80(3):674-81. PubMed ID: 22210473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Physical ageing of amorphous polymeric excipients III. The possible consequences of ageing].
    Zelkó R; Kiss D
    Acta Pharm Hung; 2006; 76(2):105-13. PubMed ID: 17094669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formulation and evaluation of Ficus glomerata mucilage sustained release matrix tablets of gliclazide.
    Kumar CS; Reddy-Budideti KK; Battula SP; Ayyavala CS
    Pak J Pharm Sci; 2011 Jul; 24(3):399. PubMed ID: 21715275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets.
    Zugasti ME; Zornoza A; Goñi Mdel M; Isasi JR; Vélaz I; Martín C; Sánchez M; Martínez-Ohárriz MC
    Drug Dev Ind Pharm; 2009 Oct; 35(10):1264-70. PubMed ID: 19555243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
    Sankalia JM; Sankalia MG; Mashru RC
    J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS; Shimpi SL; Paradkar AR
    Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel three-layered tablet for extended release with various layer formulations and in vitro release profiles.
    Park JS; Shim JY; Park JS; Choi YW; Jeong SH
    Drug Dev Ind Pharm; 2011 Jun; 37(6):664-72. PubMed ID: 21449708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Salted Anionic-Cationic Polymethacrylate Polymer Blends for Sustained Release of Acidic and Basic Drugs.
    Obeidat WM; Qasim D; Nokhodchi A; Al-Jabery A; Sallam AS
    Curr Drug Deliv; 2017; 14(1):109-122. PubMed ID: 27138298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of liquisolid formulations on dissolution of naproxen.
    Tiong N; Elkordy AA
    Eur J Pharm Biopharm; 2009 Nov; 73(3):373-84. PubMed ID: 19679184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biowaiver monographs for immediate release solid oral dosage forms: metronidazole.
    Rediguieri CF; Porta V; G Nunes DS; Nunes TM; Junginger HE; Kopp S; Midha KK; Shah VP; Stavchansky S; Dressman JB; Barends DM
    J Pharm Sci; 2011 May; 100(5):1618-27. PubMed ID: 21374600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.